Skip to main content
. 2016 Nov 28;74(8):1527–1551. doi: 10.1007/s00018-016-2426-4

Fig. 4.

Fig. 4

TcdB induces G2/M cell-cycle arrest in EGCs. Control EGCs and EGCs treated with TcdB (0.1–10 ng/ml) were recovered at 1.5–48 h. The analysis of the cell percentages in the cell-cycle phases was determined by flow cytometry with ModFit software. Cell percentages in G0/G1, S and G2/M are reported. The results of one experiment representative of six are shown